This information is for educational purposes only. Off-label drug use carries risks. Always consult a qualified physician before using any drug outside its approved indication.
Atorvastatin (Statin)
Atorvastatin Calcium
Brand names: Lipitor, Torvast
ORIGINALLY APPROVED FOR
High Cholesterol, Cardiovascular Disease Prevention
Statins inhibit HMG-CoA reductase — the rate-limiting enzyme of the mevalonate pathway — which is critical not just for cholesterol synthesis but for producing geranylgeranyl pyrophosphate (GGPP) and farnesyl pyrophosphate (FPP). Cancer cells depend heavily on these molecules to activate Rho and Ras GTPases — key oncogenic drivers. Epidemiological studies show statin users have 10–30% lower risk for several cancers, with strongest evidence in colorectal and breast cancer.
Molecular Pathways Targeted
Mechanism of Action in Cancer
Blocks mevalonate pathway → depletes GGPP and FPP → prevents geranylgeranylation and farnesylation of Rho/Ras proteins → inhibits their membrane anchoring → Rho/Ras become inactive → reduced cancer cell proliferation, migration, and survival. Also induces apoptosis and autophagy in cancer cells.
Cancers Studied
Typical Off-Label Dosing
10–80 mg daily (standard cardiovascular dosing). Higher-dose statins (40–80 mg) appear more active in cancer models. Lipophilic statins (atorvastatin, simvastatin, lovastatin) cross into cells more readily than hydrophilic ones (rosuvastatin).
* Dosing information from research literature only. Not a prescription. Requires physician supervision.
Cautions & Drug Interactions
- Risk of myopathy and rhabdomyolysis — especially with high doses or CYP3A4 inhibitors
- Liver enzyme elevation — monitor LFTs at baseline and periodically
- Avoid in pregnancy and breastfeeding
- Drug interactions: azole antifungals, macrolide antibiotics, grapefruit juice increase statin levels
- Small increased risk of new-onset diabetes at high doses
- Co-Q10 depletion — some practitioners recommend CoQ10 supplementation